| Literature DB >> 25957127 |
Yuan Liu1, Aihua Wu1, Jing Hu2, Manman Lin2, Mengtang Wen2, Xiao Zhang2, Chongxin Xu2, Xiaodan Hu2, Jianfeng Zhong2, Lingxia Jiao2, Yajing Xie2, Cunzhen Zhang2, Xiangyang Yu2, Ying Liang2, Xianjin Liu3.
Abstract
3-Phenoxybenzoic acid (3-PBA) is a general metabolite of synthetic pyrethroids. It could be used as a generic biomarker for multiple pyrethroids exposure for human or pyrethroid residues in the environment. In this study, monoclonal antibodies (mAbs) against 3-PBA were developed by using PBA-bovine serum albumin (BSA) as an immunogen. In the competitive enzyme-linked immunosorbent assay (ELISA) format, the I50 and I10 values of purified mAbs were 0.63 and 0.13 μg/ml, respectively, with a dynamic range between 0.19 and 2.04 μg/ml. Then, the colloidal gold (CG)-based lateral flow immunoassay was established based on the mAbs. The working concentration of coating antigen and CG-labeled antibodies and the blocking effects were investigated to get optimal assay performance. The cutoff value for the assay was 1 μg/ml 3-PBA, and the detection time was within 10 min. A total of 40 river water samples were spiked with 3-PBA at different levels and determined by the lateral flow immunoassay without any sample pretreatments. The negative false rate was 2.5%, and no positive false results were observed at these levels. This lateral flow immunoassay has the potential to be an on-site screening method for monitoring 3-PBA or pyrethroid residues in environmental samples.Entities:
Keywords: 3-Phenoxybenzoic acid; Colloidal gold; Lateral flow immunoassay; Monoclonal antibodies
Mesh:
Substances:
Year: 2015 PMID: 25957127 DOI: 10.1016/j.ab.2015.04.022
Source DB: PubMed Journal: Anal Biochem ISSN: 0003-2697 Impact factor: 3.365